The intricate metabolism of pancreatic cancers

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

You may have access to this PDF.

Abstract

Oncogenic KRAS regulates glucose and glutamine metabolism in pancreatic cancer cells.MUC1 overexpression leads to increased glucose metabolism.p53 functions predict the sensitivity of pancreatic cancer tumors to glycolytic inhibition.Targeting alpha-ketoglutarate dehydrogenase function by CPI-613 to slow mitochondrial metabolism.The antidiabetic drug, metformin, targets pancreatic cancer stem cells.Combined therapy is used to target pancreatic metabolism heterogeneity.

Cite

CITATION STYLE

APA

Camelo, F., & Le, A. (2018). The intricate metabolism of pancreatic cancers. In Advances in Experimental Medicine and Biology (Vol. 1063, pp. 73–81). Springer New York LLC. https://doi.org/10.1007/978-3-319-77736-8_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free